Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
1997-06
Metadata
Show full item recordCitation
Infection and Immunity 1997 65(6):2112-2118PubMed ID
9169740PubMed Central ID
175292Language
en_USISSN
0019-95671098-5522
The following license files are associated with this item:
Related articles
- Construction and characterization of genetically-marked bivalent anti-Shigella dysenteriae 1 and anti-Shigella flexneri Y live vaccine candidates.
- Authors: Klee SR, Tzschaschel BD, Singh M, Fält I, Lindberg AA, Timmis KN, Guzmán CA
- Issue date: 1997 Jun
- Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes.
- Authors: Fält IC, Schweda EK, Klee S, Singh M, Floderus E, Timmis KN, Lindberg AA
- Issue date: 1995 Sep
- Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit.
- Authors: Wu T, Grassel C, Levine MM, Barry EM
- Issue date: 2011 Dec
- Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine.
- Authors: Venkatesan MM, Hartman AB, Newland JW, Ivanova VS, Hale TL, McDonough M, Butterton J
- Issue date: 2002 Jun
- Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
- Authors: Dharmasena MN, Hanisch BW, Wai TT, Kopecko DJ
- Issue date: 2013 Apr